TANABE NORIKAZU 田邉規和

… Alternative Names

田邉規和タナベノリカズ

Less

Researcher Number	60886448
Other IDs
Affiliation (Current)	2026: 山口大学, 医学部附属病院, 助教
Affiliation (based on the past Project Information) *help	2023 – 2024: 山口大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 52010:General internal medicine-related Except Principal Investigator Basic Section 52010:General internal medicine-related
Keywords	Principal Investigator 早期肝癌 / リキッドバイオプシー / 肝細胞癌 Except Principal Investigator リキッドバイオプシー / リキッドバイオプシー検査 / 肝細胞癌

早期肝癌発見を可能とするリキッドバイオプシー検査体制の構築
- Principal Investigator
  
  山崎隆弘
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Yamaguchi University
早期肝癌治療におけるリキッドバイオプシー検査による新たな統合インデックスの有用性Principal Investigator
- Principal Investigator
  
  田邉規和
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Yamaguchi University

All 2025 2024 2023

All Journal Article Presentation

[Journal Article] Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma2025
- Author(s)
  TANABE NORIKAZU、SAEKI ISSEI、YAMAOKA KENJI、KAWAOKA TOMOKAZU、TOMONARI TETSU、TANI JOJI、TERASHIMA TAKESHI、KAWAMURA YUSUKE、OKA SHIRO、TAKAYAMA TETSUJI、KOBARA HIDEKI、YAMASHITA TARO、AKUTA NORIO、YAMASAKI TAKAHIRO、TAKAMI TARO
- Journal Title
  
  Anticancer Research
  
  Volume: 45 Issue: 3 Pages: 1117-1125
- DOI
  10.21873/anticanres.17499
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K16984, KAKENHI-PROJECT-23K27508
[Journal Article] Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy2024
- Author(s)
  Saeki I、Shimose S、Tomonari T、Ito T、Tani J、Takeuchi Y、Yoshioka N、Naito T、Takeuchi M、Kakizaki S、Hatanaka T、Sasaki K、Yasunaka T、Sakata M、Iwamoto H、Itano S、Shirono T、Tanabe N、Yamamoto T、Kanayama Y、Naganuma A、Nishina S、Otsuka M、Kobara H、Kawashima H、Takayama T、Kawaguchi T、Yamasaki T、Takami T
- Journal Title
  
  PLOS ONE
  
  Volume: 19 Issue: 9 Pages: e0311084-e0311084
- DOI
  10.1371/journal.pone.0311084
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27508
[Journal Article] Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma2024
- Author(s)
  Kunimune Yuki、Suehiro Yutaka、Saeki Issei、Yamauchi Yurika、Tanabe Norikazu、Matsumoto Toshihiko、Higaki Shingo、Fujii Ikuei、Suzuki Chieko、Okayama Naoko、Nishioka Mitsuaki、Ichihara Kiyoshi、Nagano Hiroaki、Sakaida Isao、Takami Taro、Yamasaki Takahiro
- Journal Title
  
  Liver Cancer
  
  Volume: - Issue: 5 Pages: 1-11
- DOI
  10.1159/000536211
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27508, KAKENHI-PROJECT-23K06885
[Journal Article] Varying Impact of Lenvatinib or Sorafenib Therapy on Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma2024
- Author(s)
  Yamauchi Yurika、Saeki Issei、Fujisawa Koichi、Egusa Maho、Nishiyama Natsuko、Fujioka Tsuyoshi、Kawamoto Daiki、Sasaki Ryo、Nishimura Tatsuro、Tanabe Norikazu、Hisanaga Takuro、Matsumoto Toshihiko、Ishikawa Tsuyoshi、Yamasaki Takahiro、Takami Taro
- Journal Title
  
  Oncology
  
  Volume: - Issue: 9 Pages: 1-6
- DOI
  10.1159/000536501
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27587, KAKENHI-PROJECT-23K27508, KAKENHI-PROJECT-22K08057, KAKENHI-PROJECT-24K18765
[Journal Article] Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma2023
- Author(s)
  Tanabe N、Saeki I、Aibe Y、Matsuda T、Hanazono T、Nishi M、Hidaka I、Kuwashiro S、Shiratsuki S、Egusa M、Nishiyama N、Fujioka T、Kawamoto D、Sasaki R、Nishimura T、Oono T、Hisanaga T、Matsumoto T、Ishikawa T、Yamasaki T、Takami T
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 11 Pages: 2927-2927
- DOI
  10.3390/cancers15112927
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K27508
[Journal Article] Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.2023
- Author(s)
  Saeki I, Suehiro Y, Yamauchi Y, Hoshida T, Tanabe N, Oono T, Kawamoto D, Nishimura T, Matsumoto T, Ishikawa T, Shimokawa M, Tamori A, Kawada N, Tamai Y, Iwasa M, Nakagawa H, Nagano H, Takami T, Yamasaki T
- Journal Title
  
  Hepatol Int
  
  Volume: 17 Issue: 5 Pages: 1289-1299
- DOI
  10.1007/s12072-023-10488-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24322, KAKENHI-PROJECT-23K27508
[Presentation] メチル化SEPT9を用いたアブレーション後再発予測の検討2025
- Author(s)
  江種真穂、佐伯一成、藤岡　毅、田邉規和、山﨑隆弘、高見太郎
- Organizer
  第3回日本アブレーション研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Advanced stage肝細胞癌に対するatezolizumab/bevacizumab併用療法の治療前奏効因子の検討2024
- Author(s)
  田邉規和、佐伯一成、江種真穂、西山夏子、藤岡　毅、川本大樹、佐々木　嶺、西村達朗、松本俊彦、石川　剛、山﨑隆弘、高見太郎
- Organizer
  第60回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Pretreatment Predictors of Response to Combination Therapy with Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma2024
- Author(s)
  Norikazu Tanabe, Issei Saeki, Maho Egusa, Tsuyoshi Fujioka, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL Oncology 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Novel Integrated Index ASDAm-H1 for Diagnosing Early-stage Hepatocellular Carcinoma2024
- Author(s)
  Takahiro Yamasaki, Issei Saeki, Yuki Kunimune, Yutaka Suehiro, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Masumoto, Naoka Okayama, Mituaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Taro Takami
- Organizer
  ILCA2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma2024
- Author(s)
  Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Naoko Okayama, Mitsuaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki
- Organizer
  APASL2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] A case of unresectable HCC treated with durvalumab/tremelimumab followed by conversion surgery2024
- Author(s)
  Naho Egusa, Issei Saeki, Tsuyoshi Fugioka, Natsuko Nishiyama, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Norikazu tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 当院におけるChild-Pugh Bの切除不能肝細胞癌に対するDurvalumab単剤投与の経験2024
- Author(s)
  田邉規和、佐伯一成、桐原愛果、江種真穂、西山夏子、藤岡　毅、川本大樹、佐々木　嶺、西村達朗、松本俊彦、石川　剛、山﨑隆弘、高見太郎
- Organizer
  第30回日本肝がん分子標的治療研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] The Importance of Assessing Energy Malnutrition in Atezolizumab/Bevacizumab Therapy2024
- Author(s)
  Maho Egusa, Issei Saeki, Tsuyoshi Fujioka, Norikazu Tanabe, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL Oncology 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 後天性血栓性血小板減少性紫斑病を発症した切除不能肝細胞癌に対してLEN-TACEが奏効した一例2024
- Author(s)
  藤岡　毅、佐伯一成、江種真穂、西山夏子、川本大樹、佐々木　嶺、西村達朗、田邉規和、松本俊彦、石川　剛、山本　薫、能野翔太、太田康晴、山﨑隆弘、高見太郎
- Organizer
  第60回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Atezolizumab/bevacizumab療法におけるエネルギー低栄養評価の重要性2024
- Author(s)
  江種真穂、佐伯一成、藤岡　毅、西山夏子、川本大樹、佐々木　嶺、西村達朗、田邉規和、松本俊彦、石川　剛、山﨑隆弘、高見太郎
- Organizer
  第60回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] A Case of Consciously Selected LEN-TACE for Unresectable HCC Combined with Acquired Thrombocytopenia Purpura2024
- Author(s)
  Tsuyoshi Fujioka, Issei Saeki, Maho Egusa, Natsuko Nishiyama, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Norikazu Tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Kaoru Yamamoto, Syota Nono, Yasuharu Ota, Takahiro Yamasaki, Taro Takami
- Organizer
  APASL Oncology 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Impact of Methylated SEPT9 Liquid Biopsy Test as a Prognostic Biomarker in Hepatocellular Carcinoma2024
- Author(s)
  Issei Saeki, Takahiro Yamasaki, Maho Egusa, Norikazu Tanabe, Yuki Kunimune, Yutaka Suehiro, Taro Takami
- Organizer
  APASL2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 慢性腎不全合併肝細胞癌に対して血液透析を導入し集学的治療を施行している1例2023
- Author(s)
  藤岡毅, 佐伯一成, 江種真穂, 西山夏子, 川本大樹, 田邉規和, 西村達朗, 大野高嗣, 石川剛, 山﨑隆弘, 高見太郎
- Organizer
  第59回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 肝細胞癌に対してcabozantinib内服中に急速に毛髪変色を来した一例2023
- Author(s)
  江種真穂, 田邉規和, 西山夏子, 藤岡毅, 川本大樹, 西村達朗, 大野高嗣, 佐伯一成, 松本俊彦, 石川剛, 山﨑隆弘, 高見太郎
- Organizer
  第59回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] Atezolizumab+Bevacizumab療法後の骨転移に対する姑息的放射線治療でアブスコパル効果により著効が得られた肝細胞癌の一例2023
- Author(s)
  江種真穂, 佐伯一成, 西山夏子, 藤岡毅, 川本大樹, 佐々木領, 西村達朗, 田邉規和, 松本俊彦, 石川剛, 山﨑隆弘, 高見太郎
- Organizer
  第45回日本肝臓学会西部会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] メチル化SEPT9によるリキッドバイオプシー検査は肝癌診断性能の未来を変える2023
- Author(s)
  佐伯一成, 江種真穂, 西山夏子, 藤岡毅, 川本大樹, 田邉規和, 大野高嗣, 西村達朗, 松本俊彦, 石川剛, 山﨑隆弘, 高見太郎
- Organizer
  第59回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 肝予備能による進行肝癌の治療戦略2023
- Author(s)
  佐伯一成, 田邉規和, 高見太郎, 山﨑隆弘, 坂井田功
- Organizer
  第115回日本消化器病学会中国支部例会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 肝細胞癌に対する一次治療としてのアテゾリズマブ/ベバシズマブおよびレンバチニブ治療におけるメチル化SEPT9を標的としたリキッドバイオプシーの意義2023
- Author(s)
  佐伯一成, 江種真穂, 藤岡毅, 西山夏子, 田邉規和, 大野高嗣, 川本大樹, 西村達朗, 松本俊彦, 石川剛, 末廣寛, 山﨑隆弘, 高見太郎
- Organizer
  第109回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-23K27508
[Presentation] 低分化型・混合型肝癌に対するアテゾリズマブ・ベバシズマブとレンバチニブの治療効果の比較2023
- Author(s)
  田邉規和, 佐伯一成, 江種真穂, 西山夏子, 藤岡毅, 川本大樹, 西村達朗, 大野高嗣, 松本俊彦, 石川剛, 山﨑隆弘, 高見太郎
- Organizer
  第59回日本肝癌研究会
- Data Source
  KAKENHI-PROJECT-23K27508

1. 山崎隆弘 (00304478)

# of Collaborated Projects: 1 results

# of Collaborated Products: 22 results
2. 石川剛 (20569305)

# of Collaborated Projects: 1 results

# of Collaborated Products: 13 results
3. 末廣寛 (40290978)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 佐伯一成 (60634756)

# of Collaborated Projects: 1 results

# of Collaborated Products: 22 results
5. SUEHIRO Yutaka

# of Collaborated Projects: 0 results

# of Collaborated Products: 5 results
6. FUJISAWA Koichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 寺島健志

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 河田則文

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 高見太郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 松本俊彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

TANABE NORIKAZU 田邉 規和

田邉 規和 タナベ ノリカズ

Research Projects

Research Products

Co-Researchers

早期肝癌発見を可能とするリキッドバイオプシー検査体制の構築

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

早期肝癌治療におけるリキッドバイオプシー検査による新たな統合インデックスの有用性Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma2025

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Varying Impact of Lenvatinib or Sorafenib Therapy on Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.2023

Author(s)

Journal Title

DOI

Data Source

[Presentation] メチル化SEPT9を用いたアブレーション後再発予測の検討2025

Author(s)

Organizer

Data Source

[Presentation] Advanced stage肝細胞癌に対するatezolizumab/bevacizumab併用療法の治療前奏効因子の検討2024

Author(s)

Organizer

Data Source

[Presentation] Pretreatment Predictors of Response to Combination Therapy with Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma2024

Author(s)

Organizer

Data Source

[Presentation] Novel Integrated Index ASDAm-H1 for Diagnosing Early-stage Hepatocellular Carcinoma2024

Author(s)

Organizer

Data Source

[Presentation] Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma2024

Author(s)

Organizer

Data Source

[Presentation] A case of unresectable HCC treated with durvalumab/tremelimumab followed by conversion surgery2024

Author(s)

Organizer

Data Source

[Presentation] 当院におけるChild-Pugh Bの切除不能肝細胞癌に対するDurvalumab単剤投与の経験2024

Author(s)

Organizer

Data Source

[Presentation] The Importance of Assessing Energy Malnutrition in Atezolizumab/Bevacizumab Therapy2024

Author(s)

Organizer

Data Source

[Presentation] 後天性血栓性血小板減少性紫斑病を発症した切除不能肝細胞癌に対してLEN-TACEが奏効した一例2024

TANABE NORIKAZU 田邉規和

田邉規和タナベノリカズ